Midgard Science

Labs / Assays & in vitro testing

R

RudaCure

Incheon, South Korea · rudacure.com

RudaCure is a Korean drug discovery company focused on membrane proteins, including ion channels and GPCRs. It develops therapeutics for dry eye disease, chronic pain, psoriasis, and rare neurological disease, with offices in Incheon and Seoul, Korea.

They take quote requests by email.

What they offer

  • Pharmacology evaluation

    Evaluates drug candidates in pharmacology studies for membrane-targeted programs.

  • In vivo assessment

    Conducts in vivo studies as part of its CRO offering.

  • In vitro assessment

    Conducts in vitro studies as part of its CRO offering.

  • Ion-channel screening

    Screens candidates for ion-channel activity and selectivity.

  • Ocular-disease animal models

    Uses ocular-disease animal models for preclinical evaluation.

What they work on

Modalities
ADC, Peptide, Viral vector, Cell therapy
Species and models
ocular-disease animal models, dry eye disease model, Sjögren's syndrome model
Assays and studies
electrophysiology, patch clamp, high-throughput electrophysiology, pharmacology evaluation, ion-channel screening, AI-based molecular prediction, structure-based design, molecular dynamics simulations
Therapeutic areas
dry eye disease, chronic pain, psoriasis, rare neurological disease, sensory disease, inflammatory disease, veterinary dry eye
Type
CRO
Sites
Incheon, Korea · Seoul, Korea
Serves
Korea, US, Japan, Europe
Founded
2018

Similar labs. Genevoyager, ProtaGene, Sai Life, 3C Therapeutics

Found in a contract services directory. Listing built from rudacure.com. Work here? Claim this listing.

RudaCure · Midgard Science